{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:27:31Z","timestamp":1776742051726,"version":"3.51.2"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Niemann-Pick Disease Type C (NPC) is an inherited, often fatal neurovisceral lysosomal storage disease characterized by cholesterol accumulation in every cell with few known treatments. Defects in cholesterol transport cause sequestration of unesterified cholesterol within the endolysosomal system. The discovery that systemic administration of hydroxypropyl-beta cyclodextrin (HP\u03b2PD) to NPC mice could release trapped cholesterol from lysosomes, normalize cholesterol levels in the liver, and prolong life, led to expanded access use in NPC patients. HP\u03b2CD has been administered to NPC patients with approved INDs globally since 2009.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Here we present safety, tolerability and efficacy data from 12 patients treated intravenously (IV) for over 7\u2009years with HP\u03b2CD in the US and Brazil. Some patients subsequently received intrathecal (IT) treatment with HP\u03b2CD following on average 13\u2009months of IV HP\u03b2CD. Several patients transitioned to an alternate HP\u03b2CD. Moderately affected NPC patients treated with HP\u03b2CD showed slowing of disease progression. Severely affected patients demonstrated periods of stability but eventually showed progression of disease. Neurologic and neurocognitive benefits were seen in most patients with IV alone, independent of the addition of IT administration. Physicians and caregivers reported improvements in quality of life for the patients on IV therapy. There were no safety issues, and the drug was well tolerated and easy to administer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These expanded access data support the safety and potential benefit of systemic IV administration of HP\u03b2CD and provide a platform for two clinical trials to study the effect of intravenous administration of HP\u03b2CD in NPC patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-019-1207-1","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T15:21:33Z","timestamp":1571671293000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Expanded access with intravenous hydroxypropyl-\u03b2-cyclodextrin to treat children and young adults with Niemann-Pick disease type C1: a case report analysis"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3149-0762","authenticated-orcid":false,"given":"Caroline","family":"Hastings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benny","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Bascon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Hrynkow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-5-16","volume":"5","author":"MT Vanier","year":"2010","unstructured":"Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1207_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/03007995.2017.1294054","volume":"33","author":"CJ Hendriksz","year":"2017","unstructured":"Hendriksz CJ, Anheim M, Bauer P, Bonnot O, Chakrapani A, Corvol JC, et al. The hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease. Curr Med Res Opin. 2017;33(5):877\u201390.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"1207_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","volume":"106","author":"MC Patterson","year":"2012","unstructured":"Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F, et al. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106(3):330\u201344.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"1207_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/CPJ.0000000000000399","volume":"7","author":"MC Patterson","year":"2017","unstructured":"Patterson MC, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O, et al. Recommendations for the detection and diagnosis of Niemann-Pick disease type C: an update. Neurol Clin Pract. 2017;7(6):499\u2013511.","journal-title":"Neurol Clin Pract"},{"issue":"1\u20132","key":"1207_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymgme.2009.06.008","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Group N-CGW, Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2009;98(1\u20132):152\u201365.","journal-title":"Mol Genet Metab"},{"issue":"11","key":"1207_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/ajmg.a.31735","volume":"143A","author":"WS Garver","year":"2007","unstructured":"Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, et al. The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A. 2007;143A(11):1204\u201311.","journal-title":"Am J Med Genet A"},{"issue":"23","key":"1207_CR7","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","volume":"82","author":"PG Pentchev","year":"1985","unstructured":"Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA, Patel S, et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A. 1985;82(23):8247\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"1207_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ymgme.2016.11.008","volume":"120","author":"MC Patterson","year":"2017","unstructured":"Patterson MC, Walkley SU. Niemann-Pick disease, type C and Roscoe Brady. Mol Genet Metab. 2017;120(1\u20132):34\u20137.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"1207_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.tibs.2005.07.007","volume":"30","author":"YA Ioannou","year":"2005","unstructured":"Ioannou YA. Guilty until proven innocent: the case of NPC1 and cholesterol. Trends Biochem Sci. 2005;30(9):498\u2013505.","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"1207_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1034\/j.1399-0004.2003.00147.x","volume":"64","author":"MT Vanier","year":"2003","unstructured":"Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet. 2003;64(4):269\u201381.","journal-title":"Clin Genet"},{"key":"1207_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/bs.mcb.2014.10.028","volume":"126","author":"MT Vanier","year":"2015","unstructured":"Vanier MT, Latour P. Laboratory diagnosis of Niemann-Pick disease type C: the filipin staining test. Methods Cell Biol. 2015;126:357\u201375.","journal-title":"Methods Cell Biol"},{"issue":"25","key":"1207_CR12","doi-asserted-by":"publisher","first-page":"26167","DOI":"10.1074\/jbc.M311591200","volume":"279","author":"D te Vruchte","year":"2004","unstructured":"te Vruchte D, Lloyd-Evans E, Veldman RJ, Neville DC, Dwek RA, Platt FM, et al. Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport. J Biol Chem. 2004;279(25):26167\u201375.","journal-title":"J Biol Chem"},{"issue":"4","key":"1207_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1600-0854.2010.01032.x","volume":"11","author":"E Lloyd-Evans","year":"2010","unstructured":"Lloyd-Evans E, Platt FM. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic. 2010;11(4):419\u201328.","journal-title":"Traffic"},{"key":"1207_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1172-8-12","volume":"8","author":"MC Patterson","year":"2013","unstructured":"Patterson MC, Mengel E, Wijburg FA, Muller A, Schwierin B, Drevon H, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 2","key":"1207_CR15","doi-asserted-by":"publisher","first-page":"S542","DOI":"10.1007\/s00415-014-7385-9","volume":"261","author":"M Strupp","year":"2014","unstructured":"Strupp M, Kremmyda O, Adamczyk C, Bottcher N, Muth C, Yip CW, et al. Central ocular motor disorders, including gaze palsy and nystagmus. J Neurol. 2014;261(Suppl 2):S542\u201358.","journal-title":"J Neurol"},{"issue":"Pt 1","key":"1207_CR16","first-page":"120","volume":"130","author":"M Sevin","year":"2007","unstructured":"Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-Pick disease type C. Brain. 2007;130(Pt 1):120\u201333.","journal-title":"Brain"},{"issue":"12","key":"1207_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1212\/01.wnl.0000345040.01917.9d","volume":"72","author":"LA Abel","year":"2009","unstructured":"Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology. 2009;72(12):1083\u20136.","journal-title":"Neurology"},{"key":"1207_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1196\/annals.1325.041","volume":"1039","author":"D Solomon","year":"2005","unstructured":"Solomon D, Winkelman AC, Zee DS, Gray L, Buttner-Ennever J. Niemann-Pick type C disease in two affected sisters: ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci. 2005;1039:436\u201345.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1207_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1468-1331.2011.03545.x","volume":"19","author":"M Walterfang","year":"2012","unstructured":"Walterfang M, Macfarlane MD, Looi JC, Abel L, Bowman E, Fahey MC, et al. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol. 2012;19(3):462\u20137.","journal-title":"Eur J Neurol"},{"issue":"12","key":"1207_CR20","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1177\/0883073812464526","volume":"28","author":"P Karimzadeh","year":"2013","unstructured":"Karimzadeh P, Tonekaboni SH, Ashrafi MR, Shafeghati Y, Rezayi A, Salehpour S, et al. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series. J Child Neurol. 2013;28(12):1599\u2013606.","journal-title":"J Child Neurol"},{"issue":"6","key":"1207_CR21","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s10072-012-1155-1","volume":"33","author":"E Salsano","year":"2012","unstructured":"Salsano E, Umeh C, Rufa A, Pareyson D, Zee DS. Vertical supranuclear gaze palsy in Niemann-Pick type C disease. Neurol Sci. 2012;33(6):1225\u201332.","journal-title":"Neurol Sci"},{"issue":"9","key":"1207_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","volume":"6","author":"MC Patterson","year":"2007","unstructured":"Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6(9):765\u201372.","journal-title":"Lancet Neurol"},{"issue":"20","key":"1207_CR23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1212\/WNL.0b013e3182563b82","volume":"78","author":"FA Wijburg","year":"2012","unstructured":"Wijburg FA, Sedel F, Pineda M, Hendriksz CJ, Fahey M, Walterfang M, et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78(20):1560\u20137.","journal-title":"Neurology"},{"key":"1207_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12883-015-0511-1","volume":"15","author":"J Imrie","year":"2015","unstructured":"Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol. 2015;15:257.","journal-title":"BMC Neurol"},{"issue":"9","key":"1207_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/dmcn.13476","volume":"59","author":"Anne Marie Winstone","year":"2017","unstructured":"Winstone AM, Stellitano LA, Verity CM. Niemann-Pick type C as a cause of progressive intellectual and neurological deterioration in childhood. Dev Med Child Neurol. 2017;59(9):965-72.","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"3","key":"1207_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ymgme.2009.06.009","volume":"98","author":"JE Wraith","year":"2009","unstructured":"Wraith JE, Guffon N, Rohrbach M, Hwu WL, Korenke GC, Bembi B, et al. Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. Mol Genet Metab. 2009;98(3):250\u20134.","journal-title":"Mol Genet Metab"},{"key":"1207_CR27","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","volume":"113","author":"MT Vanier","year":"2013","unstructured":"Vanier MT. Niemann-Pick diseases. Handb Clin Neurol. 2013;113:1717\u201321.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"1207_CR28","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.10541","volume":"18","author":"C Battisti","year":"2003","unstructured":"Battisti C, Tarugi P, Dotti MT, De Stefano N, Vattimo A, Chierichetti F, et al. Adult onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study. Mov Disord. 2003;18(11):1405\u20139.","journal-title":"Mov Disord"},{"issue":"8","key":"1207_CR29","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/jnnp.2005.086785","volume":"77","author":"G Trendelenburg","year":"2006","unstructured":"Trendelenburg G, Vanier MT, Maza S, Millat G, Bohner G, Munz DL, et al. Niemann-Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry. 2006;77(8):997\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1207_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1212\/WNL.0b013e31828869f9","volume":"80","author":"J Schicks","year":"2013","unstructured":"Schicks J, Muller Vom Hagen J, Bauer P, Beck-Wodl S, Biskup S, Krageloh-Mann I, et al. Niemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy. Neurology. 2013;80(12):1169\u201370.","journal-title":"Neurology"},{"key":"1207_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgmr.2015.02.004","volume":"3","author":"CR Greenberg","year":"2015","unstructured":"Greenberg CR, Barnes JG, Kogan S, Seargeant LE. A rare case of Niemann-Pick disease type C without neurological involvement in a 66-year-old patient. Mol Genet Metab Rep. 2015;3:18\u201320.","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"1207_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ymgme.2016.12.003","volume":"120","author":"E Mengel","year":"2017","unstructured":"Mengel E, Pineda M, Hendriksz CJ, Walterfang M, Torres JV, Kolb SA. Differences in Niemann-Pick disease type C symptomatology observed in patients of different ages. Mol Genet Metab. 2017;120(3):180\u20139.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"1207_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13256-016-0925-4","volume":"10","author":"AV Degtyareva","year":"2016","unstructured":"Degtyareva AV, Mikhailova SV, Zakharova EY, Tumanova EL, Puchkova AA. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report. J Med Case Rep. 2016;10(1):143.","journal-title":"J Med Case Rep"},{"key":"1207_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.12688\/wellcomeopenres.11854.1","volume":"2","author":"WRH Evans","year":"2017","unstructured":"Evans WRH, Nicoli ER, Wang RY, Movsesyan N, Platt FM. Case report: Ursodeoxycholic acid treatment in Niemann-Pick disease type C; clinical experience in four cases. Wellcome Open Res. 2017;2:75.","journal-title":"Wellcome Open Res"},{"issue":"10","key":"1207_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00431-015-2540-6","volume":"174","author":"Robert Hegarty","year":"2015","unstructured":"Hegarty R, Hadzie N, Gissen P, Dhawan A. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King's College Hospital experience. Eur J Pediatr. 2015;174:1387-92.","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"1207_CR36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00408-016-9893-0","volume":"194","author":"FM von Ranke","year":"2016","unstructured":"von Ranke FM, Pereira Freitas HM, Mancano AD, Rodrigues RS, Hochhegger B, Escuissato D, et al. Pulmonary involvement in Niemann-Pick disease: a state-of-the-art review. Lung. 2016;194(4):511\u20138.","journal-title":"Lung"},{"issue":"3","key":"1207_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10072-005-0456-z","volume":"26","author":"S Palmeri","year":"2005","unstructured":"Palmeri S, Tarugi P, Sicurelli F, Buccoliero R, Malandrini A, De Santi MM, et al. Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage. Neurol Sci. 2005;26(3):171\u20133.","journal-title":"Neurol Sci"},{"issue":"11","key":"1207_CR38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00431-018-3219-6","volume":"177","author":"Orna Staretz-Chacham","year":"2018","unstructured":"Staretz-Chacham O, Aviram M, Morag I, Goldbart A, Hershkovitz E. Pulmonary invovlement in Niemann-Pick C type 1. Eur J Pediatr. 2018;177(11):1609-15.","journal-title":"European Journal of Pediatrics"},{"key":"1207_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-015-0284-z","volume":"10","author":"MC Patterson","year":"2015","unstructured":"Patterson MC, Mengel E, Vanier MT, Schwierin B, Muller A, Cornelisse P, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study. Orphanet J Rare Dis. 2015;10:65.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1207_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymgme.2008.10.002","volume":"96","author":"D Galanaud","year":"2009","unstructured":"Galanaud D, Tourbah A, Lehericy S, Leveque N, Heron B. Billette de Villemeur T, et al. 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy. Mol Genet Metab. 2009;96(2):55\u20138.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1207_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","volume":"98","author":"M Pineda","year":"2009","unstructured":"Pineda M, Wraith JE, Mengel E, Sedel F, Hwu WL, Rohrbach M, et al. Miglustat in patients with Niemann-Pick disease type C (NP-C): a multicenter observational retrospective cohort study. Mol Genet Metab. 2009;98(3):243\u20139.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"1207_CR42","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ymgme.2009.11.007","volume":"99","author":"M Pineda","year":"2010","unstructured":"Pineda M, Perez-Poyato MS, O\u2019Callaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab. 2010;99(4):358\u201366.","journal-title":"Mol Genet Metab"},{"key":"1207_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13023-015-0240-y","volume":"10","author":"S Fecarotta","year":"2015","unstructured":"Fecarotta S, Romano A, Della Casa R, Del Giudice E, Bruschini D, Mansi G, et al. Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C. Orphanet J Rare Dis. 2015;10:22.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1207_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","volume":"99","author":"JE Wraith","year":"2010","unstructured":"Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab. 2010;99(4):351\u20137.","journal-title":"Mol Genet Metab"},{"key":"1207_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2147\/TCRM.S5777","volume":"5","author":"JE Wraith","year":"2009","unstructured":"Wraith JE, Imrie J. New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat. Ther Clin Risk Manag. 2009;5:877\u201387.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"1207_CR46","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajmg.b.30969","volume":"153B","author":"NM Yanjanin","year":"2010","unstructured":"Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK, et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(1):132\u201340.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"1207_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ymgme.2013.07.019","volume":"110","author":"VM Ginocchio","year":"2013","unstructured":"Ginocchio VM, D'Amico A, Bertini E, Ceravolo F, Dardis A, Verrigni D, et al. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience. Mol Genet Metab. 2013;110(3):329\u201335.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"1207_CR48","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","volume":"59","author":"ME Brewster","year":"2007","unstructured":"Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev. 2007;59(7):645\u201366.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"1207_CR49","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1002\/jps.23077","volume":"101","author":"T Loftsson","year":"2012","unstructured":"Loftsson T, Brewster ME. Cyclodextrins as functional excipients: methods to enhance complexation efficiency. J Pharm Sci. 2012;101(9):3019\u201332.","journal-title":"J Pharm Sci"},{"issue":"7","key":"1207_CR50","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm1073","volume":"10","author":"LD Griffin","year":"2004","unstructured":"Griffin LD, Gong W, Verot L, Mellon SH. Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med. 2004;10(7):704\u201311.","journal-title":"Nat Med"},{"issue":"6","key":"1207_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/jnr.20685","volume":"82","author":"I Ahmad","year":"2005","unstructured":"Ahmad I, Lope-Piedrafita S, Bi X, Hicks C, Yao Y, Yu C, et al. Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice. J Neurosci Res. 2005;82(6):811\u201321.","journal-title":"J Neurosci Res"},{"issue":"37","key":"1207_CR52","doi-asserted-by":"publisher","first-page":"13807","DOI":"10.1073\/pnas.0606218103","volume":"103","author":"SJ Langmade","year":"2006","unstructured":"Langmade SJ, Gale SE, Frolov A, Mohri I, Suzuki K, Mellon SH, et al. Pregnane X receptor (PXR) activation: a mechanism for neuroprotection in a mouse model of Niemann-Pick C disease. Proc Natl Acad Sci U S A. 2006;103(37):13807\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1207_CR53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1194\/jlr.M700525-JLR200","volume":"49","author":"B Liu","year":"2008","unstructured":"Liu B, Li H, Repa JJ, Turley SD, Dietschy JM. Genetic variations and treatments that affect the lifespan of the NPC1 mouse. J Lipid Res. 2008;49(3):663\u20139.","journal-title":"J Lipid Res"},{"issue":"2","key":"1207_CR54","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0024-3205(01)01384-4","volume":"70","author":"F Camargo","year":"2001","unstructured":"Camargo F, Erickson RP, Garver WS, Hossain GS, Carbone PN, Heidenreich RA, et al. Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci. 2001;70(2):131\u201342.","journal-title":"Life Sci"},{"issue":"7","key":"1207_CR55","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","volume":"106","author":"B Liu","year":"2009","unstructured":"Liu B, Turley SD, Burns DK, Miller AM, Repa JJ, Dietschy JM. Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1\u2212\/\u2212 mouse. Proc Natl Acad Sci U S A. 2009;106(7):2377\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1207_CR56","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1194\/jlr.M028241","volume":"53","author":"AM Taylor","year":"2012","unstructured":"Taylor AM, Liu B, Mari Y, Liu B, Repa JJ. Cyclodextrin mediates rapid changes in lipid balance in Npc1\u2212\/\u2212 mice without carrying cholesterol through the bloodstream. J Lipid Res. 2012;53(11):2331\u201342.","journal-title":"J Lipid Res"},{"issue":"4","key":"1207_CR57","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/PDR.0b013e3181ee4dd2","volume":"68","author":"CM Ramirez","year":"2010","unstructured":"Ramirez CM, Liu B, Taylor AM, Repa JJ, Burns DK, Weinberg AG, et al. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr Res. 2010;68(4):309\u201315.","journal-title":"Pediatr Res"},{"key":"1207_CR58","unstructured":"Available from: http:\/\/addiandcassi.com\/category\/cyclodextrin\/fda-cyclodextrin-filings\/ ."},{"issue":"6","key":"1207_CR59","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1248\/bpb.b14-00726","volume":"38","author":"Y Tanaka","year":"2015","unstructured":"Tanaka Y, Yamada Y, Ishitsuka Y, Matsuo M, Shiraishi K, Wada K, et al. Efficacy of 2-hydroxypropyl-beta-cyclodextrin in Niemann-Pick disease type C model mice and its pharmacokinetic analysis in a patient with the disease. Biol Pharm Bull. 2015;38(6):844\u201351.","journal-title":"Biol Pharm Bull"},{"issue":"276","key":"1207_CR60","doi-asserted-by":"publisher","first-page":"276ra26","DOI":"10.1126\/scitranslmed.3010101","volume":"7","author":"CH Vite","year":"2015","unstructured":"Vite CH, Bagel JH, Swain GP, Prociuk M, Sikora TU, Stein VM, et al. Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease. Sci Transl Med. 2015;7(276):276ra26.","journal-title":"Sci Transl Med"},{"issue":"9","key":"1207_CR61","doi-asserted-by":"publisher","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","volume":"4","author":"CD Davidson","year":"2009","unstructured":"Davidson CD, Ali NF, Micsenyi MC, Stephney G, Renault S, Dobrenis K, et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One. 2009;4(9):e6951.","journal-title":"PLoS One"},{"issue":"20","key":"1207_CR62","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA"},{"issue":"4","key":"1207_CR63","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1172\/JCI119223","volume":"99","author":"V M Atger","year":"1997","unstructured":"Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest. 1997;99(4):773-80","journal-title":"Journal of Clinical Investigation"},{"issue":"12","key":"1207_CR64","doi-asserted-by":"publisher","first-page":"9290","DOI":"10.1074\/jbc.M111.326405","volume":"287","author":"KB Peake","year":"2012","unstructured":"Peake KB, Vance JE. Normalization of cholesterol homeostasis by 2-hydroxypropyl-beta-cyclodextrin in neurons and glia from Niemann-Pick C1 (NPC1)-deficient mice. J Biol Chem. 2012;287(12):9290\u20138.","journal-title":"J Biol Chem"},{"issue":"25","key":"1207_CR65","doi-asserted-by":"publisher","first-page":"9404","DOI":"10.1523\/JNEUROSCI.1317-11.2011","volume":"31","author":"A Aqul","year":"2011","unstructured":"Aqul A, Liu B, Ramirez CM, Pieper AA, Estill SJ, Burns DK, et al. Unesterified cholesterol accumulation in late endosomes\/lysosomes causes neurodegeneration and is prevented by driving cholesterol export from this compartment. J Neurosci. 2011;31(25):9404\u201313.","journal-title":"J Neurosci"},{"issue":"4","key":"1207_CR66","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1194\/jlr.M013789","volume":"52","author":"CM Ramirez","year":"2011","unstructured":"Ramirez CM, Liu B, Aqul A, Taylor AM, Repa JJ, Turley SD, et al. Quantitative role of LAL, NPC2, and NPC1 in lysosomal cholesterol processing defined by genetic and pharmacological manipulations. J Lipid Res. 2011;52(4):688\u201398.","journal-title":"J Lipid Res"},{"issue":"1","key":"1207_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2006.05.054","volume":"249","author":"C Iturriaga","year":"2006","unstructured":"Iturriaga C, Pineda M, Fernandez-Valero EM, Vanier MT, Coll MJ. Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci. 2006;249(1):1\u20136.","journal-title":"J Neurol Sci"},{"issue":"4","key":"1207_CR68","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ymgme.2016.06.004","volume":"118","author":"MT Vanier","year":"2016","unstructured":"Vanier MT, Gissen P, Bauer P, Coll MJ, Burlina A, Hendriksz CJ, et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review. Mol Genet Metab. 2016;118(4):244\u201354.","journal-title":"Mol Genet Metab"},{"key":"1207_CR69","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13023-015-0274-1","volume":"10","author":"AK Giese","year":"2015","unstructured":"Giese AK, Mascher H, Grittner U, Eichler S, Kramp G, Lukas J, et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis. 2015;10:78.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"1207_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2016-0340","volume":"55","author":"G Polo","year":"2017","unstructured":"Polo G, Burlina AP, Kolamunnage TB, Zampieri M, Dionisi-Vici C, Strisciuglio P, et al. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS. Clin Chem Lab Med. 2017;55(3):403\u201314.","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"1207_CR71","doi-asserted-by":"publisher","first-page":"e114669","DOI":"10.1371\/journal.pone.0114669","volume":"9","author":"RW Welford","year":"2014","unstructured":"Welford RW, Garzotti M, Marques Lourenco C, Mengel E, Marquardt T, Reunert J, et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. PLoS One. 2014;9(12):e114669.","journal-title":"PLoS One"},{"issue":"3","key":"1207_CR72","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s002470050114","volume":"27","author":"T Noda","year":"1997","unstructured":"Noda T, Todani T, Watanabe Y, Yamamoto S. Liver volume in children measured by computed tomography. Pediatr Radiol. 1997;27(3):250\u20132.","journal-title":"Pediatr Radiol"},{"issue":"2","key":"1207_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ymgme.2011.03.001","volume":"103","author":"A Muralidhar","year":"2011","unstructured":"Muralidhar A, Borbon IA, Esharif DM, Ke W, Manacheril R, Daines M, et al. Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1(\u2212)\/(\u2212) mice. Mol Genet Metab. 2011;103(2):142\u20137.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1207_CR74","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10545-012-9583-x","volume":"36","author":"CC Pontikis","year":"2013","unstructured":"Pontikis CC, Davidson CD, Walkley SU, Platt FM, Begley DJ. Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability. J Inherit Metab Dis. 2013;36(3):491\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"1207_CR75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.arcmed.2014.11.020","volume":"45","author":"M Vecsernyes","year":"2014","unstructured":"Vecsernyes M, Fenyvesi F, Bacskay I, Deli MA, Szente L, Fenyvesi E. Cyclodextrins, blood-brain barrier, and treatment of neurological diseases. Arch Med Res. 2014;45(8):711\u201329.","journal-title":"Arch Med Res"},{"issue":"12","key":"1207_CR76","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/molecules21121748","volume":"21","author":"Caroline Coisne","year":"2016","unstructured":"Coisne C, Tilloy S, Monflier E, Wils D, Fenart L, Gosselet F. Cyclodetrins as emerging therapeutic tools in the treatment of cholesterol-associated vascular and neurodegenrative diseases. Molecules. 2016;21(12):1748.","journal-title":"Molecules"},{"issue":"12","key":"1207_CR77","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1073\/pnas.0914309107","volume":"107","author":"AI Rosenbaum","year":"2010","unstructured":"Rosenbaum AI, Zhang G, Warren JD, Maxfield FR. Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells. Proc Natl Acad Sci U S A. 2010;107(12):5477\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1207_CR78","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1471-4159.2010.06976.x","volume":"116","author":"AI Rosenbaum","year":"2011","unstructured":"Rosenbaum AI, Maxfield FR. Niemann-Pick type C disease: molecular mechanisms and potential therapeutic approaches. J Neurochem. 2011;116(5):789\u201395.","journal-title":"J Neurochem"},{"issue":"3","key":"1207_CR79","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/MOL.0b013e3283453e69","volume":"22","author":"JE Vance","year":"2011","unstructured":"Vance JE, Peake KB. Function of the Niemann-Pick type C proteins and their bypass by cyclodextrin. Curr Opin Lipidol. 2011;22(3):204\u20139.","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"1207_CR80","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1016\/j.ymgme.2010.11.148","volume":"102","author":"C Vite","year":"2011","unstructured":"Vite C, Mauldin E, Ward S, Stein V, Prociuk M, Haskins ME, et al. Intrathecal cyclodextrin therapy of feline Niemann-Pick type C disease. Mol Genet Metab. 2011;102(2):S44.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1207_CR81","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/acn3.306","volume":"3","author":"CD Davidson","year":"2016","unstructured":"Davidson CD, Fishman YI, Puskas I, Szeman J, Sohajda T, McCauliff LA, et al. Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease. Ann Clin Transl Neurol. 2016;3(5):366\u201380.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1207_CR82","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ymgme.2012.11.005","volume":"108","author":"M Matsuo","year":"2013","unstructured":"Matsuo M, Togawa M, Hirabaru K, Mochinaga S, Narita A, Adachi M, et al. Effects of cyclodextrin in two patients with Niemann\u2013Pick type C disease. Mol Genet Metab. 2013;108(1):76\u201381.","journal-title":"Mol Genet Metab"},{"key":"1207_CR83","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ymgmr.2014.08.004","volume":"1","author":"M Matsuo","year":"2014","unstructured":"Matsuo M, Shraishi K, Wada K, Ishitsuka Y, Doi H, Maeda M, et al. Effects of intracerebroventricular administration of 2-hydroxypropyl-\u03b2-cyclodextrin in a patient with Niemann\u2013Pick type C disease. Mol Genet Metab Rep. 2014;1:391\u2013400.","journal-title":"Mol Genet Metab Rep"},{"key":"1207_CR84","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jns.2016.04.048","volume":"366","author":"AA Garcia-Robles","year":"2016","unstructured":"Garcia-Robles AA, Company-Albir MJ, Megias-Vericat JE, Fernandez-Megia MJ, Perez-Miralles FC, Lopez-Briz E, et al. Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick type C patients. J Neurol Sci. 2016;366:65\u20137.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"1207_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ymgme.2015.07.001","volume":"116","author":"TJ Maarup","year":"2015","unstructured":"Maarup TJ, Chen AH, Porter FD, Farhat NY, Ory DS, Sidhu R, et al. Intrathecal 2-hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1. Mol Genet Metab. 2015;116(1\u20132):75\u20139.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"1207_CR86","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10072-017-2833-9","volume":"38","author":"JE Megias-Vericat","year":"2017","unstructured":"Megias-Vericat JE, Garcia-Robles A, Company-Albir MJ, Fernandez-Megia MJ, Perez-Miralles FC, Lopez-Briz E, et al. Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases. Neurol Sci. 2017;38(5):727\u201343.","journal-title":"Neurol Sci"},{"issue":"6","key":"1207_CR87","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1136\/gutjnl-2015-310382","volume":"66","author":"T Schwerd","year":"2017","unstructured":"Schwerd T, Pandey S, Yang HT, Bagola K, Jameson E, Jung J, et al. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn\u2019s disease. Gut. 2017;66(6):1060\u201373.","journal-title":"Gut."},{"key":"1207_CR88","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/8904_2015_454","volume":"25","author":"M Amiri","year":"2016","unstructured":"Amiri M, Kuech EM, Shammas H, Wetzel G, Naim HY. The Pathobiochemistry of gastrointestinal symptoms in a patient with Niemann-Pick type C disease. JIMD Rep. 2016;25:25\u20139.","journal-title":"JIMD Rep"},{"issue":"1","key":"1207_CR89","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13023-018-0880-9","volume":"13","author":"M Cortina-Borja","year":"2018","unstructured":"Cortina-Borja M, Te Vruchte D, Mengel E, Amraoui Y, Imrie J, Jones SA, et al. Annual severity increment score as a tool for stratifying patients with Niemann-Pick disease type C and for recruitment to clinical trials. Orphanet J Rare Dis. 2018;13(1):143.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"1207_CR90","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1399-0004.1988.tb03460.x","volume":"33","author":"MT Vanier","year":"1988","unstructured":"Vanier MT, Wenger DA, Comly ME, Rousson R, Brady RO, Pentchev PG. Niemann-Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification. A collaborative study on 70 patients. Clin Genet. 1988;33(5):331\u201348.","journal-title":"Clin Genet"},{"issue":"4","key":"1207_CR91","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0925-4439(91)90069-L","volume":"1096","author":"MT Vanier","year":"1991","unstructured":"Vanier MT, Rodriguez-Lafrasse C, Rousson R, Gazzah N, Juge MC, Pentchev PG, et al. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta. 1991;1096(4):328\u201337.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 1","key":"1207_CR92","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1007\/s10545-009-1173-1","volume":"32","author":"M Walterfang","year":"2009","unstructured":"Walterfang M, Fietz M, Abel L, Bowman E, Mocellin R, Velakoulis D. Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C. J Inherit Metab Dis. 2009;32(Suppl 1):S221\u20136.","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1207-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1207-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T09:58:39Z","timestamp":1721901519000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1207-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1207-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A data acquisition protocol was developed by the lead author (CH) and all investigators sought approval from local ethics or Institutional Review Boards. Case Report Forms (CRFs) were developed to capture patient characteristics including manifestations of disease, adverse events (AEs), details of drug administration, laboratory and clinical assessments. Informed consent was obtained from all of the subjects prior to the initiation of treatment with HP\u03b2CD in accordance to the local Institutional Review Boards and principles of ethical research according to the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent was obtained from the patient families by the investigators to participate in the data acquisition protocol with the intent to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"<b>Caroline Hastings:<\/b> Principal Investigator, Phase I Study of the pharmacokinetics of Trappsol\u00ae Cyclo\u2122 and effects on potential biomarkers of Niemann-Pick C1 (NPC1), ClinicalTrials.gov NCT02939547, CTD Holdings, Inc.; Senior clinical advisor and member of the Safety Review Committee EU Phase I\/II Study of pharmacokinetics and preliminary efficacy of Trappsol\u00ae Cyclo\u2122 in patients with Niemann-Pick C1 (NPC1), ClincialTrials.gov NCT02912793, CTD Holdings, Inc.; Co-Chair, Listening Circle, CTD Holdings, Inc.<b>Camilo Vieira:<\/b> None<b>Benny Liu:<\/b> Co-Principal Investigator, Phase I Study of the pharmacokinetics of Trappsol\u00ae Cyclo\u2122 and effects on potential biomarkers of Niemann-Pick C1 (NPC1); ClinicalTrials.gov NCT02939547, CTD Holdings, Inc.; Scientific Advisory Board, CTD Holdings, Inc.<b>Cyrus Bascon:<\/b> Clinical research associate, Data Acquisition Study of Compassionate Use HP\u03b2CD, CTD Holdings, Inc.<b>Claire Gao:<\/b> None<b>Raymond Wang:<\/b> Local Site Principal Investigator, Study of VTS-270 (2-hydroxypropyl-beta-cyclodextrin) to treat Niemann-Pick Type C1 (NPC1) disease, ClinicalTrials.gov NCT02534844, Vtesse, Inc.; Scientific Advisory Board for NPC, Sucampo Pharmaceuticals, Inc.<b>Alicia Casey:<\/b> None<b>Sharon Hrynkow:<\/b> Chief Scientific Officer and Senior Vice President for Medical Affairs; Co-Chair, Listening Circle; Co-Chair, Scientific Advisory Board, CTD Holdings, Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}